Important Update: National ADHD Medication Shortage & Care Options
We understand that the ongoing shortage of stimulant medications is both stressful and frustrating. If you’ve been affected, please know that you are not alone — and there are alternative options we can explore together to support your care.
Non-Stimulant Alternatives
Atomoxetine (Strattera): Increases norepinephrine levels and is approved for ADHD.
Guanfacine (Intuniv): Originally for high blood pressure; also helps with impulsivity and hyperactivity.
Clonidine (Kapvay): Used for both ADHD and hypertension; supports symptom control.
Bupropion (Wellbutrin): An off-label option that influences dopamine and norepinephrine.
Viloxazine (Qelbree): A newer, FDA-approved ADHD treatment that targets norepinephrine.
Alternative Stimulant Medications
Amphetamine-based options: Adderall, Adzenys XR, Evekeo, Dexedrine, Zenzedi, Vyvanse
Methylphenidate-based options: Concerta, Aptensio XR, Focalin, Metadate, Ritalin
Other stimulant formulations: Desoxyn (methamphetamine hydrochloride)
Steps You Can Take
Check with local pharmacies to see what is currently in stock.
Schedule an appointment with your provider to discuss the best alternatives for your needs.
Contact your insurance company to confirm coverage for new medications.
Communicate with work or school if changes in medication impact your schedule.
Seek support from family and friends during this transition.
Prioritize self-care through healthy routines, rest, and stress management techniques.
Please note that some cases may require a detailed appointment to review your options thoroughly. While we do our best to respond promptly, occasional delays may occur. Pharmacy change requests may also involve additional fees — please check our website or ask for details.
Thank you for your patience and understanding as we work together to navigate this shortage. Our commitment remains to provide you with the best possible care and to adjust your treatment plan as needed.
